Idursulfatase therapy in mucopolysaccharidosis type II: after 2.5 years of treatment--no benefit for older patients with multisystem involvement.
Gucev, Zoran S
Idursulfatase therapy in mucopolysaccharidosis type II: after 2.5 years of treatment--no benefit for older patients with multisystem involvement. [electronic resource] - Pediatric neurology Mar 2012 - 199-200; author reply 200 p. digital
Publication Type: Letter; Comment
1873-5150
10.1016/j.pediatrneurol.2012.01.006 doi
Enzyme Replacement Therapy
Humans
Iduronate Sulfatase--therapeutic use
Male
Mucopolysaccharidosis II--drug therapy
Idursulfatase therapy in mucopolysaccharidosis type II: after 2.5 years of treatment--no benefit for older patients with multisystem involvement. [electronic resource] - Pediatric neurology Mar 2012 - 199-200; author reply 200 p. digital
Publication Type: Letter; Comment
1873-5150
10.1016/j.pediatrneurol.2012.01.006 doi
Enzyme Replacement Therapy
Humans
Iduronate Sulfatase--therapeutic use
Male
Mucopolysaccharidosis II--drug therapy